Sh. Rajiv. Oil (530295)

Score breakdown: P/E: 0/3 · ROCE: 0/2 · Growth: 0/2 · Dividend: 0/1

Key Financials

Strengths

• Book value of ₹12.49 per share provides a tangible net worth reference while the stock trades at ₹17.95.
• Trailing twelve-month earnings are positive, so the company is not yet in a full-year loss state.
• Tiny ₹8 Cr market cap could offer outsized percentage gains if a genuine operational turnaround emerges.

Concerns

• Latest quarter shows zero sales and zero net profit, suggesting the business may have stalled.
• ROCE is negative at -2.44% and ROE is only 2.70%, indicating poor capital efficiency.
• Piotroski F-Score of 2/9 points to weak financial health and high distress risk.
• Price of ₹17.95 is below the 52-week low of ₹21.46, with no dividend and missing promoter-holding data.

AI Analysis

In my investing life, I try to buy a wonderful business at a fair price, not a weak business at a low price. Sh. Rajiv Oil fails the first test: it is not a wonderful business. Return on equity is only 2.70%, and return on capital employed is -2.44%. The company is not earning its keep; it is destroying incremental capital. Sales growth is 0.00%, profit growth is -60.00%, and the latest quarter shows ₹0 Cr sales and ₹0 Cr net profit. The engine is not running. The P/E of 95.29 is meaningless as a value measure because the earnings base is tiny and collapsing. The P/B of 1.44 means I pay ₹17.95 for book value of ₹12.49; there is no margin of safety. Piotroski score of 2/9 confirms the financial condition is weak. There is no dividend to reward patience. The stock is trading below its 52-week low of ₹21.46—the market is telling me to stay away. Add to that promoter holding is N/A, and even the FairStock Score is N/A due to insufficient data. Graham would insist on adequate analysis; inadequate data is a reason to refuse, not to gamble. At ₹8 crore market cap, this is a micro-cap with little buffer against shocks. I can see no moat, no pricing power, no growth engine. This is not a current value investment. It might someday become a turnaround if operations restart and cash flows improve, but today the evidence does not support the price. I would keep this on the 'too hard' pile and wait for either a much lower price, preferably below book value, or clear proof of a genuine operating recovery.

Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer